Pfizer's $11.6 bn Biohaven buy could spark more biotech dealsThe deal, announced on Tuesday, is the biggest in the sector so far this year and ends a dearth of large acquisitions, which along with cli...
S&P 500, Nasdaq end higher in choppy session as inflation data loomsTechnology and growth stocks, whose valuations rely more heavily on future cash flows, have been among the hardest hit in the recent sellof...
Pfizer to acquire Biohaven by early 2023 for $11.6 billionBiohaven Pharmaceutical Holding Company Ltd. and Pfizer Inc. announced that both the companies have entered into an agreement wherein Pfize...
S&P 500 ends down as Russia-Ukraine tensions heat upBy the closing bell, the Dow Jones Industrial Average joined the S&P 500 in negative territory, while the Nasdaq Composite Index ended esse...